DUBLIN–(BUSINESS WIRE)–The “In Vitro Toxicology Testing Market by Product & Service (Assays (ELISA & Western Blot), Equipment, Consumable, Software), Toxicity Endpoints (ADME, Genotoxicity, Cytotoxicity), Technology, Method, Industry (Pharma, Cosmetics) – Global Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering.
The in vitro toxicology testing market is projected to reach USD 17.1 billion by 2028 from an estimated USD 10.8 billion in 2023, at a CAGR of 9.5%
The growth of this market can be attributed to the technological advancements in toxicology equipment, research and development efforts aimed at early-stage toxicity detection, and growing focus on drug discovery and personalized medicine using in vitro toxicology testing methods and increasing focus on predictive toxicology.
The consumables segment accounted for the largest share by product & services in 2022.
In 2022, the consumables segment accounted for the largest share of products & services in the global In vitro toxicology testing market. The factors like growing focus on improving product safety across industries, such as pharmaceutical, food, cosmetics, and chemicals, are driving the demand for consumables in the in vitro toxicology testing market.
The increasing demand for high-quality reagents and the repeated use of media and reagents in vitro toxicology studies are also driving the growth of this market. Furthermore, the market share of the consumables market is expected to grow simultaneously with the increasing adoption of in vitro toxicology testing across various industries.
Europe has continued to dominate the in vitro toxicology testing market during the forecast period of 2023-2028.
The ban on animal testing in the region is the major factor driving the adoption of in vitro toxicology testing across all industries. Europe dominated the global in vitro toxicology testing market in 2022. This dominance is attributed to the presence of over 33 scientific facilities and research centers, often associated with cosmetic manufacturers, fostering a dynamic and highly innovative cosmetics industry.
Additionally, the region is experiencing increased investments in biologics and advanced dosage forms, partly driven by the impending patent expiration of numerous blockbuster drugs. The growing need to expedite the drug development process, which typically spans 10 to 12 years, has further fueled the demand for in vitro toxicology testing.
Notably, the European Union has been at the forefront of supporting research for the development and validation of advanced in vitro toxicology testing protocols for regulatory purposes. Consequently, the European market is witnessing growth due to the development of novel drugs and personal care products, the research and development efforts of EU member states to find alternatives to animal testing, and the ban on cosmetics tested on animals.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 414 |
| Forecast Period | 2023 – 2028 |
| Estimated Market Value (USD) in 2023 | $10.8 Billion |
| Forecasted Market Value (USD) by 2028 | $17.1 Billion |
| Compound Annual Growth Rate | 9.5% |
| Regions Covered | Global |
Premium Insights
- Public Resistance Against Animal Testing to Drive Market
- Cellular Assays Accounted for Largest Share of Asia-Pacific in Vitro Toxicology Testing Market in 2022
- Germany to Register Highest Growth During Forecast Period
- Consumables Accounted for Largest Market Share in 2022
Market Dynamics
Market Drivers
- Growing Public Resistance Against Animal Testing
- Technological Advancements
- Research and Development Efforts Aimed at Early-Stage Toxicity Detection
Market Restraints
- Resistance of Certain Regulatory Bodies to Embrace Alternative Approaches in Toxicology Testing
- Failure to Establish Intricacies of in Vivo Conditions
- Lack of In Vitro Models to Study Complex Endpoints
Market Opportunities
- Growing Focus on Drug Discovery and Personalized Medicine Using in Vitro Methods
- Increasing Number of Toxicology Databases
- Increasing Focus on Predictive Toxicology
Market Challenges
- Lack of Data Availability and Validation
- Complexity in Data Analysis and Management
Company Profiles
- Agilent Technologies, Inc.
- Aragen Life Sciences Ltd.
- Bio-Rad Laboratories, Inc.
- Bioivt
- Catalent, Inc.
- Charles River Laboratories
- Creative Bioarray
- Creative Biolabs
- Enzo Biochem Inc.
- Eurofins Scientific
- Evotec Se
- Inotiv
- Intertek Group plc
- Laboratory Corporation of America Holdings
- Lonza
- MB Research Laboratories
- Merck KGaA
- Microbac Laboratories, Inc.
- Pacific Biolabs, Inc.
- Promega Corporation
- Revvity
- SGS SA
- Shanghai Medicilon Inc.
- Thermo Fisher Scientific Inc.
- Vimta Labs Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/dzf5bm
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900